Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease risk.

Langston ME, Bhalla A, Alderete JF, Nevin RL, Pakpahan R, Hansen J, Elliott D, De Marzo AM, Gaydos CA, Isaacs WB, Nelson WG, Sokoll LJ, Zenilman JM, Platz EA, Sutcliffe S.

Prostate. 2019 Oct;79(14):1622-1628. doi: 10.1002/pros.23886. Epub 2019 Aug 2.

PMID:
31376187
2.

Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA.

Wang C, Höti N, Lih TM, Sokoll LJ, Zhang R, Zhang Z, Zhang H, Chan DW.

Clin Proteomics. 2019 Apr 6;16:13. doi: 10.1186/s12014-019-9234-4. eCollection 2019.

3.

A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma.

Song J, Merbs SL, Sokoll LJ, Chan DW, Zhang Z.

Clin Proteomics. 2019 Mar 5;16:10. doi: 10.1186/s12014-019-9230-8. eCollection 2019.

4.

Validation of a novel model for the early detection of hepatocellular carcinoma.

Hemken PM, Sokoll LJ, Yang X, Dai J, Elliott D, Gawel SH, Lucht M, Feng Z, Marrero JA, Srivastava S, Chan DW, Davis GJ.

Clin Proteomics. 2019 Jan 16;16:2. doi: 10.1186/s12014-018-9222-0. eCollection 2019.

5.

Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.

Song J, Sokoll LJ, Pasay JJ, Rubin AL, Li H, Bach DM, Chan DW, Zhang Z.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):174-182. doi: 10.1158/1055-9965.EPI-18-0483. Epub 2018 Oct 17.

PMID:
30333219
6.

Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-up.

Langston ME, Pakpahan R, Nevin RL, De Marzo AM, Elliott DJ, Gaydos CA, Isaacs WB, Nelson WG, Sokoll LJ, Zenilman JM, Platz EA, Sutcliffe S.

Prostate. 2018 Sep;78(13):1024-1034. doi: 10.1002/pros.23660. Epub 2018 May 30.

7.

Eltrombopag mobilizes iron in patients with aplastic anemia.

Zhao Z, Sun Q, Sokoll LJ, Streiff M, Cheng Z, Grasmeder S, Townsley DM, Young NS, Dunbar CE, Winkler T.

Blood. 2018 May 24;131(21):2399-2402. doi: 10.1182/blood-2018-01-826784. Epub 2018 Apr 9. No abstract available. Erratum in: Blood. 2018 Jul 26;132(4):459.

8.

Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.

Druskin SC, Tosoian JJ, Young A, Collica S, Srivastava A, Ghabili K, Macura KJ, Carter HB, Partin AW, Sokoll LJ, Ross AE, Pavlovich CP.

BJU Int. 2018 Apr;121(4):619-626. doi: 10.1111/bju.14098. Epub 2018 Jan 9.

9.

Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults.

Li D, Radulescu A, Shrestha RT, Root M, Karger AB, Killeen AA, Hodges JS, Fan SL, Ferguson A, Garg U, Sokoll LJ, Burmeister LA.

JAMA. 2017 Sep 26;318(12):1150-1160. doi: 10.1001/jama.2017.13705.

10.

Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method.

Whelton SP, Meeusen JW, Donato LJ, Jaffe AS, Saenger A, Sokoll LJ, Blumenthal RS, Jones SR, Martin SS.

J Clin Lipidol. 2017 Jul - Aug;11(4):1065-1072. doi: 10.1016/j.jacl.2017.05.005. Epub 2017 Jun 1.

PMID:
28826567
11.

Insight into infection-mediated prostate damage: Contrasting patterns of C-reactive protein and prostate-specific antigen levels during infection.

Milbrandt M, Winter AC, Nevin RL, Pakpahan R, Bradwin G, De Marzo AM, Elliott DJ, Gaydos CA, Isaacs WB, Nelson WG, Rifai N, Sokoll LJ, Zenilman JM, Platz EA, Sutcliffe S.

Prostate. 2017 May;77(13):1325-1334. doi: 10.1002/pros.23392. Epub 2017 Jul 12.

12.

Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.

Sanda MG, Feng Z, Howard DH, Tomlins SA, Sokoll LJ, Chan DW, Regan MM, Groskopf J, Chipman J, Patil DH, Salami SS, Scherr DS, Kagan J, Srivastava S, Thompson IM Jr, Siddiqui J, Fan J, Joon AY, Bantis LE, Rubin MA, Chinnayian AM, Wei JT; and the EDRN-PCA3 Study Group, Bidair M, Kibel A, Lin DW, Lotan Y, Partin A, Taneja S.

JAMA Oncol. 2017 Aug 1;3(8):1085-1093. doi: 10.1001/jamaoncol.2017.0177.

13.

Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance.

Tosoian JJ, Patel HD, Mamawala M, Landis P, Wolf S, Elliott DJ, Epstein JI, Carter HB, Ross AE, Sokoll LJ, Pavlovich CP.

Prostate Cancer Prostatic Dis. 2017 Sep;20(3):339-342. doi: 10.1038/pcan.2017.16. Epub 2017 Apr 18.

14.

Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice.

Tosoian JJ, Druskin SC, Andreas D, Mullane P, Chappidi M, Joo S, Ghabili K, Agostino J, Macura KJ, Carter HB, Schaeffer EM, Partin AW, Sokoll LJ, Ross AE.

Prostate Cancer Prostatic Dis. 2017 Jun;20(2):228-233. doi: 10.1038/pcan.2016.72. Epub 2017 Jan 24.

15.

Prostate Health Index density improves detection of clinically significant prostate cancer.

Tosoian JJ, Druskin SC, Andreas D, Mullane P, Chappidi M, Joo S, Ghabili K, Mamawala M, Agostino J, Carter HB, Partin AW, Sokoll LJ, Ross AE.

BJU Int. 2017 Dec;120(6):793-798. doi: 10.1111/bju.13762. Epub 2017 Feb 6.

16.

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.

Visvanathan K, Fackler MS, Zhang Z, Lopez-Bujanda ZA, Jeter SC, Sokoll LJ, Garrett-Mayer E, Cope LM, Umbricht CB, Euhus DM, Forero A, Storniolo AM, Nanda R, Lin NU, Carey LA, Ingle JN, Sukumar S, Wolff AC.

J Clin Oncol. 2017 Mar;35(7):751-758. doi: 10.1200/JCO.2015.66.2080. Epub 2016 Nov 21.

17.

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer.

Andreas D, Tosoian JJ, Landis P, Wolf S, Glavaris S, Lotan TL, Schaeffer EM, Sokoll LJ, Ross AE.

Urol Case Rep. 2016 May 26;7:64-6. doi: 10.1016/j.eucr.2016.04.012. eCollection 2016 Jul.

18.

Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer.

Simmons AR, Clarke CH, Badgwell DB, Lu Z, Sokoll LJ, Lu KH, Zhang Z, Bast RC Jr, Skates SJ.

Int J Gynecol Cancer. 2016 Jul;26(6):1070-7. doi: 10.1097/IGC.0000000000000737.

19.

The Creation of a Biocontainment Unit at a Tertiary Care Hospital. The Johns Hopkins Medicine Experience.

Garibaldi BT, Kelen GD, Brower RG, Bova G, Ernst N, Reimers M, Langlotz R, Gimburg A, Iati M, Smith C, MacConnell S, James H, Lewin JJ, Trexler P, Black MA, Lynch C, Clarke W, Marzinke MA, Sokoll LJ, Carroll KC, Parish NM, Dionne K, Biddison EL, Gwon HS, Sauer L, Hill P, Newton SM, Garrett MR, Miller RG, Perl TM, Maragakis LL.

Ann Am Thorac Soc. 2016 May;13(5):600-8. doi: 10.1513/AnnalsATS.201509-587PS.

PMID:
27057583
20.

Advances in mass spectrometry-based clinical biomarker discovery.

Crutchfield CA, Thomas SN, Sokoll LJ, Chan DW.

Clin Proteomics. 2016 Jan 7;13:1. doi: 10.1186/s12014-015-9102-9. eCollection 2016. Review.

21.

Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men.

Schwen ZR, Tosoian JJ, Sokoll LJ, Mangold L, Humphreys E, Schaeffer EM, Partin AW, Ross AE.

Urology. 2016 Apr;90:136-40. doi: 10.1016/j.urology.2015.12.004. Epub 2015 Dec 10.

PMID:
26688190
22.

Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection.

Sutcliffe S, Nevin RL, Pakpahan R, Elliott DJ, Langston ME, De Marzo AM, Gaydos CA, Isaacs WB, Nelson WG, Sokoll LJ, Walsh PC, Zenilman JM, Cersovsky SB, Platz EA.

Int J Cancer. 2016 May 1;138(9):2221-30. doi: 10.1002/ijc.29966. Epub 2016 Jan 21.

23.

Urinary Biomarkers for Prostate Cancer.

Tosoian JJ, Ross AE, Sokoll LJ, Partin AW, Pavlovich CP.

Urol Clin North Am. 2016 Feb;43(1):17-38. doi: 10.1016/j.ucl.2015.08.003. Review.

PMID:
26614026
24.

Non-linearity within the primary measurement range of a lipase assay as the cause of a gap in the interpatient lipase results distribution.

Vogel AN, Goldsmith BM, Marzinke MA, Sokoll LJ, Stickle DF.

Clin Biochem. 2016 Jan;49(1-2):176-9. doi: 10.1016/j.clinbiochem.2015.10.002. Epub 2015 Oct 22.

PMID:
26474511
25.

Multiplexed Targeted Mass Spectrometry-Based Assays for the Quantification of N-Linked Glycosite-Containing Peptides in Serum.

Thomas SN, Harlan R, Chen J, Aiyetan P, Liu Y, Sokoll LJ, Aebersold R, Chan DW, Zhang H.

Anal Chem. 2015 Nov 3;87(21):10830-8. doi: 10.1021/acs.analchem.5b02063. Epub 2015 Oct 21.

26.

Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?

Sokoll LJ, Zhang Z, Chan DW, Reese AC, Bivalacqua TJ, Partin AW, Walsh PC.

J Urol. 2016 Feb;195(2):330-6. doi: 10.1016/j.juro.2015.08.080. Epub 2015 Aug 22.

PMID:
26307160
27.

The Authors' Reply.

Jialal I, Rashidi HH, Sokoll LJ.

Am J Clin Pathol. 2015 Jul;144(1):174. No abstract available.

PMID:
26263572
28.

Can Unmanned Aerial Systems (Drones) Be Used for the Routine Transport of Chemistry, Hematology, and Coagulation Laboratory Specimens?

Amukele TK, Sokoll LJ, Pepper D, Howard DP, Street J.

PLoS One. 2015 Jul 29;10(7):e0134020. doi: 10.1371/journal.pone.0134020. eCollection 2015.

29.

Low high-sensitivity troponin I and zero coronary artery calcium score identifies coronary CT angiography candidates in whom further testing could be avoided.

Korley FK, George RT, Jaffe AS, Rothman RE, Sokoll LJ, Fernandez C, Falk H, Post WS, Saheed MO, Gerstenblith G, Berkowitz SA, Hill PM.

Acad Radiol. 2015 Aug;22(8):1060-7. doi: 10.1016/j.acra.2015.04.007. Epub 2015 Jun 3.

PMID:
26049777
30.

Fluctuating creatinine in the cardiac unit.

Petrides AK, Ness MA, Judge DP, Sokoll LJ, Marzinke MA.

Clin Chim Acta. 2015 Jul 20;447:52-4. doi: 10.1016/j.cca.2015.05.012. Epub 2015 May 23.

PMID:
26014810
31.

Clinical utility of lactate dehydrogenase: a historical perspective.

Jialal I, Sokoll LJ.

Am J Clin Pathol. 2015 Feb;143(2):158-9. doi: 10.1309/AJCTP0FC8QFYDFA. No abstract available.

PMID:
25596240
32.

The prostate health index selectively identifies clinically significant prostate cancer.

Loeb S, Sanda MG, Broyles DL, Shin SS, Bangma CH, Wei JT, Partin AW, Klee GG, Slawin KM, Marks LS, van Schaik RH, Chan DW, Sokoll LJ, Cruz AB, Mizrahi IA, Catalona WJ.

J Urol. 2015 Apr;193(4):1163-9. doi: 10.1016/j.juro.2014.10.121. Epub 2014 Nov 15.

33.

Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance.

Korley FK, Schulman SP, Sokoll LJ, DeFilippis AP, Stolbach AI, Bayram JD, Saheed MO, Omron R, Fernandez C, Lwin A, Cai SS, Post WS, Jaffe AS.

Acad Emerg Med. 2014 Jul;21(7):727-35. doi: 10.1111/acem.12417. Epub 2014 Aug 11.

34.

A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.

Wu P, Sokoll LJ, Kudrolli TA, Chowdhury WH, Ma R, Liu MM, Rodriguez R, Lupold SE.

Prostate. 2014 Sep;74(13):1286-1296. doi: 10.1002/pros.22845. Epub 2014 Jul 25.

35.

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.

Ankerst DP, Hoefler J, Bock S, Goodman PJ, Vickers A, Hernandez J, Sokoll LJ, Sanda MG, Wei JT, Leach RJ, Thompson IM.

Urology. 2014 Jun;83(6):1362-7. doi: 10.1016/j.urology.2014.02.035.

36.

Measurement of fine-needle aspiration thyroglobulin levels increases the detection of metastatic papillary thyroid carcinoma in cystic neck lesions.

Holmes BJ, Sokoll LJ, Li QK.

Cancer Cytopathol. 2014 Jul;122(7):521-6. doi: 10.1002/cncy.21413. Epub 2014 Mar 3.

37.

Glow stick or urine sample?

Henemyre-Harris CL, Samols M, Wenick AS, Sokoll LJ.

Clin Chem. 2014 Feb;60(2):425-6. doi: 10.1373/clinchem.2013.205013. No abstract available.

38.

Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes for the detection of metastatic papillary thyroid carcinoma.

Li QK, Nugent SL, Straseski J, Cooper D, Riedel S, Askin FB, Sokoll LJ.

Cancer Cytopathol. 2013 Aug;121(8):440-8. doi: 10.1002/cncy.21285. Epub 2013 Mar 12.

39.

Retraction: Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.

Schoen RE, Magheli A, Sokoll LJ, Chan DW, Getzenberg RH.

Clin Cancer Res. 2013 Jan 15;19(2):508. doi: 10.1158/1078-0432.CCR-12-2711. Epub 2012 Dec 27.

40.

Retraction. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.

Schoen RE, Weissfeld JL, Sokoll LJ, Chan DW, Cannon GW, Getzenberg RH.

Cancer Res. 2013 Jan 15;73(2):1034. doi: 10.1158/0008-5472.CAN-12-3286. Epub 2012 Dec 27. No abstract available.

41.

Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration.

Loeb S, Sokoll LJ, Broyles DL, Bangma CH, van Schaik RH, Klee GG, Wei JT, Sanda MG, Partin AW, Slawin KM, Marks LS, Mizrahi IA, Shin SS, Cruz AB, Chan DW, Roberts WL, Catalona WJ.

J Urol. 2013 May;189(5):1702-6. doi: 10.1016/j.juro.2012.11.149. Epub 2012 Nov 30.

42.

Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer.

Tosoian JJ, Loeb S, Feng Z, Isharwal S, Landis P, Elliot DJ, Veltri R, Epstein JI, Partin AW, Carter HB, Trock B, Sokoll LJ.

J Urol. 2012 Oct;188(4):1131-6. doi: 10.1016/j.juro.2012.06.009. Epub 2012 Aug 15.

43.

Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.

Liu T, Hossain M, Schepmoes AA, Fillmore TL, Sokoll LJ, Kronewitter SR, Izmirlian G, Shi T, Qian WJ, Leach RJ, Thompson IM, Chan DW, Smith RD, Kagan J, Srivastava S, Rodland KD, Camp DG 2nd.

J Proteomics. 2012 Aug 3;75(15):4747-57. doi: 10.1016/j.jprot.2012.01.035. Epub 2012 Feb 13.

44.

Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassay.

Sokoll LJ, Chan DW, Klee GG, Roberts WL, van Schaik RH, Arockiasamy DA, Broyles DL, Carlson CM, Mizrahi IA, Pierson TB, Tam JE.

Clin Chim Acta. 2012 Aug 16;413(15-16):1279-83. doi: 10.1016/j.cca.2012.04.015. Epub 2012 Apr 20.

PMID:
22542565
45.

Prostate-specific antigen concentration in young men: new estimates and review of the literature.

Sutcliffe S, Pakpahan R, Sokoll LJ, Elliott DJ, Nevin RL, Cersovsky SB, Walsh PC, Platz EA.

BJU Int. 2012 Dec;110(11):1627-35. doi: 10.1111/j.1464-410X.2012.11111.x. Epub 2012 Apr 13. Review.

46.

Origin of a false positive urine pregnancy test in a patient with membranoproliferative glomerulonephritis type I.

Marzinke MA, Jarrar P, Atkinson M, Humphrey RL, Detrick B, Sokoll LJ.

Clin Chim Acta. 2012 Jan 18;413(1-2):361-3. doi: 10.1016/j.cca.2011.10.011. Epub 2011 Oct 15.

PMID:
22024216
47.

Improvement and multicenter evaluation of the analytical performance of an automated chemiluminescent immunoassay for alpha fetoprotein.

Morota K, Komori M, Fujinami R, Yamada K, Kuribayashi K, Watanabe N, Sokoll LJ, Elliott D, Chan DW, Martens F, Heijboer AC, Blankenstein MA, Hershberger SJ, Pfeiffer ZA, Vaidya SV, Dowell BL.

Int J Biol Markers. 2012 Jan-Mar;27(1):39-46. doi: 10.5301/JBM.2011.8738.

PMID:
22020369
48.

Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology.

Wilson DH, Hanlon DW, Provuncher GK, Chang L, Song L, Patel PP, Ferrell EP, Lepor H, Partin AW, Chan DW, Sokoll LJ, Cheli CD, Thiel RP, Fournier DR, Duffy DC.

Clin Chem. 2011 Dec;57(12):1712-21. doi: 10.1373/clinchem.2011.169540. Epub 2011 Oct 13.

49.

Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study.

Lepor H, Cheli CD, Thiel RP, Taneja SS, Laze J, Chan DW, Sokoll LJ, Mangold L, Partin AW.

BJU Int. 2012 Jun;109(12):1770-5. doi: 10.1111/j.1464-410X.2011.10568.x. Epub 2011 Oct 12.

50.

Is the WHO 90:10 prostate-specific antigen (PSA) first international reference standard really 90% α1-antichymotrypsin-bound PSA and 10% free PSA?

Sokoll LJ, Rosenwald S, Lyons J, Elliott DJ, Chan DW.

Clin Chem. 2011 Dec;57(12):1776-7. doi: 10.1373/clinchem.2011.172726. Epub 2011 Oct 10. No abstract available.

Supplemental Content

Loading ...
Support Center